
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Johnson & Johnson Company Info
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
News & Analysis
How to Calculate the Number of Shares of Common Stock Outstanding
Meet the Only 2 Game-Changing Businesses With a Higher Credit Rating Than the U.S. Government
In 1980, around five dozen publicly traded companies held the highest possible credit rating (AAA) from Standard & Poor's. Today, there are only two left.
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock
Fewer contenders means fewer constraints on expanding market share.
How to Calculate Return on Assets (ROA)
All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year
Investors looking for dividend stocks at reasonable valuations have come to the right place.
This Magnificent Dividend Stock Is as Healthy as It Gets
Johnson & Johnson's latest financial checkup shows it's still in excellent health.
Investing in Life Sciences Stocks
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
Valuation
Podcast Episodes

An Investor's View of Johnson & Johnson's Talc Settlement
We also take a look at Chewy's growth initiatives.

Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
Plus, we run through some shortcuts that could help you with your financial planning.

Times Like These Are Why You Want to Own a Business Like This
Plus, a look at the 4% rule and a common misconception about retirement spending.

Making Sense of Financial Advice on TikTok
Plus a look at what to like about Johnson & Johnson.
Earnings Transcripts
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2024.
Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript
JNJ earnings call for the period ending June 30, 2024.
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
JNJ earnings call for the period ending March 31, 2024.
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
JNJ earnings call for the period ending December 31, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.